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Purpose: The multifactorial pathogenesis of coronary atherosclerotic lesion formation has
been investigated in a swine model of high cholesterol diet induced atherogenesis and
data processed by a systems approach.
Methods: Farm pigs were fed on standard or high cholesterol diet of 8 and 16 weeks
duration. Plasma assessment of total cholesterol, HDL, LDL, and ELISA of some cytokines
and ICAM-1 were performed on baseline and end-diet samples. Segments of the right
coronary artery were incubated for 24 h in serum-free medium to collect secreted proteins
and their expression analyzed by mass spectrometry. Data of plasma and tissue factors
were processed by a statistical systems inference approach: both histologic parameters of
coronary intimal thickness (IT) and of lesion area (LA) were chosen as dependent variables
(coronary atherosclerotic burden).
Results: Relations among plasma adhesion molecules, cytokines, lipoproteins, tissue
proteins and histology indexes were integrated in a model regression scheme. Bayesian
model averaging (BMA) variable selection was chosen as a method to identify relevant
factors associated to atherosclerotic burden: TNFαwas identified as an associated plasma
marker, oxLDL and HDL as relevant lipoproteins; macrophage function related antioxidant
Catalase enzyme, lysosome associated Cathepsin D, S100-A10, and Transforming
growth factor-beta-induced protein ig-h3 were identified and selected as associated to
atherogenesis outcome.
Conclusions: The results of this systems approach are consistent with the hypothesis
that, in high cholesterol diet-induced experimental atherogenesis, the interaction between
plasma cytokines, lipoproteins and artery-specific proteins, influences lesion initiation and
growth. In particular, some macrophage function related proteins are found significantly
and positively associated to atherosclerotic burden, suggesting a novel molecular
framework into the atherogenesis-inflammatory disorder.
Keywords: systems biomedicine, coronary atherogenesis, swine model, vascular inflammation, Bayesian model
averaging
INTRODUCTION
Atherogenesis is the initiating step of atherosclerosis, and can
be considered the key-point for a better understanding of the
entire process, as several factors and mechanisms are also related
to plaque progression in the clinical scenario (Weber and Noels,
2011).
Plaque initiation steps take place in the following environ-
ments:
1. Systemic blood environment (proatherogenic or atheroprotec-
tive) constituted of inflammatory and lipid factors
2. Endothelial blood-vessel interface, which expresses adhesion
molecules for monocyte intra-lesional transfer
3. Sub-endothelial intimal space, where proteoglycans retain
LDL
4. Intimal and intima-media interface, scenario for vascular
smooth cell (VSMC) phenotype switch and activation toward
migratory and proliferative conditions (Libby et al., 2010)
Traditional views of atherosclerosis, basically seen as a lipid-
based disorder, have been modified by the recognition of
the multifactorial etiology of this disease (Lamon and Hajjar,
2008), involving the interplay of genetic, phenotypic and envi-
ronmental factors that have to be integrated into a unified
scheme. According to this theory, the most likely sequence of
events occurring in the initial phase of atherosclerosis com-
prises vascular dysfunction and/or injury, monocyte recruit-
ment and foam cell formation, lipid deposition, vascular
smooth muscle cell proliferation and synthesis of extracellular
matrix (Libby, 2002). The interaction of all these factors
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confers to the resulting atherosclerotic plaque its typical
features.
In this study, circulatory systemic and locally expressed artery
factors in a high cholesterol diet animal model of coronary
atherogenesis have been collected and inter-related using a
Bayesian Model Averaging (BMA) (Leamer, 1978; Raftery, 1995)
computational approach, which is also suggested as a useful strat-
egy to unravel novel actors and pathways outlining this complex
framework.
A statistical regression framework based on BMA to account
for model uncertainty determined by many variables of heteroge-
neous nature has been used. In such circumstances, the choice
of an encompassing model is not easy, and needs to be a sta-
tistically reasonable decision. BMA is a suitable model strategy,
which presents several advantages and reasonable computational
requirements.
MATERIALS AND METHODS
EXPERIMENTAL DESIGN, CIRCULATORY-TISSUE DATA COLLECTION
AND HISTOLOGY
Animal experiment protocol was approved by the Animal Care
Committee of theMinister of Public Health according with guide-
lines (protocol number: 06/2009-B-2009/01/26). Atherogenesis
has been studied in 13 farm pigs fed on a high cholesterol (4%)
high fat (27%) diet for 8 (HF, 4 cases) and 16 weeks (HHF, 6
cases) and controls fed on standard diet (CNTL, 3 cases). Data
on plasma lipids, cytokines and cell adhesion markers have been
collected before and at the end of the diet period in all ani-
mals. Total cholesterol, High Density Lipoprotein (HDL) and
triglycerides (TG) were measured by standard enzymatic tech-
niques (Synchron CX9 Pro, Beckman Coulter Inc., Fullerton, CA,
USA). Low density lipoprotein (LDL) was calculated according
to Friedewald et al. (1972) IL-6, TNFα, and ICAM-1 were pur-
chased by Abcam (Cambridge, UK), while oxLDL was a product
of Antibodies-Online (Atlanta, GA, USA).
At the end of diet period, animals were anesthetized by intra-
muscular administration of 10mg/kg of Zoletil® and 0.05mg/Kg
of atropine, plus 5mg/kg/h of propofol intravenous infusion and
sacrificed by KCl i.v. bolus injection. Upon heart explantation, a
3mm long segment of the proximal tract of right coronary artery
(RCA), 1 cm below the ostium, was harvested and placed in serum
free solution to collect secreted/released proteins (Rocchiccioli
et al., 2013)
Following heart fixation in 10% buffered formalin (7–10 days),
5–10mm thick transverse arterial samples were collected from left
main, left anterior descending, left circumflex and right coronary
arteries for routine histologic processing for paraffin embedding.
Consecutive cross-sections were obtained from each coronary
segment (rotary microtome Microm HM 300, Bio-optica) for
Haematoxylin and Eosin, Mallory trichrome and Weigert van
Gieson staining and examined under light microscopy (Olympus
BX43, Italy) from 2× to 40× original magnification. Images
were digitized by a video system (Olympus DP20 camera, Italy)
interfaced to a computer with dedicated software (CellSens
Dimension, Olympus, Italy) for morphometric analysis. Intimal
thickness (IT, mm), i.e. maximal radial expansion of the lesion,
and lesional area (LA, mm2) i.e., entire lesion area in each
cross-section, were used as representative morphometric indexes
of overall atherosclerotic burden in each individual case. Both
mean andmedian of all the IT and LA values of all cross-sectioned
coronary lesions of each case were calculated (Viglione et al.,
2013).
LIQUID CHROMATOGRAPHY (LC) SEPARATION, MASS SPECTROMETRY
(MS) ANALYSES AND DATA POST-PROCESSING
Chromatographic separation of digested peptides obtained from
secreted proteins was performed using an Ultimate 3000 nano-
HPLC system (LC Packings, DIONEX, USA) and peptides
eluted from chromatography were directly processed using
TripleTOF™ 5600 mass spectrometer (AB SCIEX, Toronto,
Canada) (Rocchiccioli et al., 2013). MS/MS data were processed
with ProteinPilot™ Software (AB SCIEX, Toronto, Canada), using
the Paragon™ and Pro Group™ Algorithms and SwissProt 2012
as protein database for Sus scrofa. The false discovery rate (FDR)
analysis was done using the integrated tools in ProteinPilot soft-
ware and a confidence level of 95% was set. Expression data for
proteins were obtained using MarkerViewTM software 1.2.1 (AB
SCIEX). Normalization of the total artery tissue size was accom-
plished with a global normalization of profiles (total protein
content) using Marker View 1.2 software.
MATHEMATICAL MODEL APPROACH: IMPLEMENTATION OF R
ENVIRONMENT, BMA PACKAGE
Circulatory and omics data have been processed and related to
histology parameters of mean and median coronary IT and LA of
each case of HF and HHF groups. All dependent and independent
variables of diet treated cases (HF and HHF) were normalized to
average values of standard diet CNTL cases which are taken as
reference. The effect of normalization, together with a logarith-
mic transform taken to minimize variability, is a better control
of the wide range of magnitude for the absolute values of histol-
ogy, circulatory and omics variables. The independent variables
are considered plasma lipoproteins (total cholesterol, LDL, HDL)
oxidized LDL, circulatory cytokines (IL6 and TNFα, ICAM-1 and
several coronary proteins identified by LC-MS reported in the
Supplementary Table 1. At first, the model has been applied to
all diet treated cases as a whole group, while it was subsequently
applied to HF and HHF groups separately.
In general, BMA is employed when multiple models may be
statistically reasonable, and selecting a single particular model
can lead to the underestimation of the uncertainty related to the
model form underlying the variables of interest. In such cases,
BMA can quickly determine suitable models through specified
sets of explanatory variables with high likelihoods. Equivalently,
averaging across a large set of such models allows to determine
the variables which are relevant to the data generating process for
a given set of priors used in the analysis.
The implementation of BMA was done within the R environ-
ment (Raftery et al., 2010), by averaging the best models of a
certain class, and according to the approximate posterior model
probability which was computed in each case. For instance, the
class “bicreg” in the BMA R package identifies the linear regres-
sion models, and is the one chosen among other possible tested
classes. In this way the analysis has been kept at its simplest and
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most interpretable level. In particular, the option “iBMA” repre-
sents the iterated BMA method for variable selection, and works
by repeatedly calling BMA, i.e., iterating through the variables in a
fixed order based on some measure of goodness of fit. After each
call, only the variables with posterior probability greater than a
specified threshold are retained, the rest being replaced by other
variables.
The summary function was used to provide concise and sum-
marized information about the variables that have been examined
up to the last iteration. Each model, and set of variables, is
weighted and the final estimates are constructed as a weighted
average of the parameter estimates from each of the models. All
the variables are considered, but some are subject to shrinking by
setting to zero the model weights, and depending upon features
such as the choice of prior (see also Supplementary Material).
POST-PROCESSING OF MODEL RESULTS
The adopted strategies to assess relevance of model selections
were:
1. Congruence of model selection by histology indexes.
Among all selected variables, those with only IT or LA associa-
tion have been discarded. Congruence of selected variables with
both maximal radial expansion and circumferential extension of
lesions was thus ensured.
2. Congruence of model selection by regression coefficients
(value and sign).
It has also been checked whether relevant variables according to
step 1 had regression coefficients of comparable size, and similar
direction of association (negative or positive sign); this strategy
allowed for a more robust combination of factors which strongly
relate to atherogenesis outcome. Variables were discarded, when
the corresponding coefficients had comparable size and opposite
sign, indicating inappropriate selection, as well as when absolute
values were very low (<0.001) irrespective of sign congruence.
RESULTS
Circulatory and omics data (Supplementary Table 1) have been
processed by BMA and related to histology parameters of mean
and median coronary IT (mm) and LA (mm2) of HF and HHF
groups. Circulatory data were measured by antibody-based kits
and expressed as a concentration in serum. Protein data were
measured by mass spectrometry and protein expression was mea-
sured by peptide peak area using arbitrary units (normalized
counts).
SELECTED VARIABLES BY FIRST IMPLEMENTATION RUN OF THE
MODEL: ALL HIGH CHOLESTEROL DIET-TREATED ANIMALS
IT and LA are the dependent variables that have been chosen for
BMA approach to provide different and complementary infor-
mation on atherosclerotic lesions, depending on lesion shape and
its mainly eccentric or concentric growth. IT is more representa-
tive of maximal radial expansion of the lesion, whilst LA is more
related to the circumferential extension.
Also Mean and Median values of the two indexes provide
distinct information, mean values being more representative of
mild localized rather than of severe and diffuse atherosclerotic
changes: different distribution patterns of lesions are present
along each coronary artery, related to single lesion severity and
extent of coronary involvement. But generally, mean and median
values tend to coincide when lesions are present in all examined
segments, whilst they diverge when atherosclerotic changes are
localized only in few segments, such as in the proximal portion
of main coronary arteries (Figure 1).
Independent variables selected by the model as associated to
atherosclerotic burden and derived from implementations run
on all diet treated cases are reported in Table 1 (lipoproteins
and circulatory factors) and Table 2 (artery secreted proteins). As
described in the Methods section, only variables with combined
association of IT and LA histology indexes of atherosclerotic
changes are reported and considered relevant.
Among lipoproteins, oxLDL, and HDL are found significantly
associated to arterial pathology. Plasma cytokine TNFα, as well as
adhesion molecule ICAM-1 are also relevantly selected variables.
Among artery secreted proteins, the most selected and asso-
ciated to all histology indexes of atherosclerotic burden are
Catalase (CATA) and Cathepsin D (CATD). Transforming growth
factor-beta-induced protein ig-h3(BGH3), S100A10 (S10AA)
and Glyceraldehyde-3-phosphate dehydrogenase (G3P) are also
selected and are congruent with 3 out of the 4 histology indexes.
SELECTED VARIABLES BY SECOND IMPLEMENTATION RUN OF THE
MODEL: TWO DISTINCT GROUPS (HF AND HHF)
The model has been also applied to 8 weeks (HF) and 16 weeks
(HHF) high cholesterol diet treated animals separately.
When considering systemic variables, separate analysis of early
atherogenesis HF group does not provide further relevant infor-
mation in addition to what previously derived frommodel run on
pooled data: this is likely due to the limited number of HF cases
and/or to the very low grade of atherogenesis after 8 weeks high
cholesterol diet.
On the other hand, for local factors, the model selects Moesin
and Osteonectine (MOES, SPRC) that had not been picked
in the first run, as well as the already selected Apolipoprotein
A4 (APOA4), Byglican (HPLN1), G3P, BGH3 and Calpastatin
(ICAL), all related to lesion development in model run onHF and
also on HHF group data. Annexin 1 (ANXA1) is the only protein
selected from HF group omics data and unselected in HHF.
EVALUATION OF REGRESSION COEFFICIENTS IN FIRST AND SECOND
IMPLEMENTATION
Regression coefficients (absolute beta values, considering beta as
the regression coefficients) of all the selected independent vari-
ables have been analyzed as an index of robustness of results and
a qualitative measure of their relation with dependent variables
IT and LA (mean and/or median values).
In pooled case run (first implementation), analysis of con-
gruence by regression coefficients confirms systemic lipid and
proinflammatory variables associated to atherosclerotic burden
(association with at least one IT plus one LA index). A positive
association is present for oxLDL, HDL and TNFα. On the other
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FIGURE 1 | Top: Histologic features of coronary lesions in a typical
HF (panel A, fatty streak, H&E 2×, insets 10× and 20×) and
HHF case (Panel B, atheroma, H&E 4×, inset Mallory trichrome
10×). Bottom: Coronary profiling (left anterior descending artery) of
IT values of observed lesions in 11 consecutive segments of a HF
case (panel A) and in 9 consecutive segments of a HHF case
(panel B). Median of IT values is about one half of the mean of
IT values in mild localized atherosclerotic changes of HF case (left),
whilst it is equal to the mean of IT values when diffuse severe
changes are present (HHF case, right).
Table 1 | Lipoproteins and inflammatory factors.
Model selected circulatory variables
IT mean IT median LA mean
IT median ICAM-1 BAS, IL6 BAS
LA mean TNFα BAS TNFα END-DIET
LA median OX-LDL END-DIET HDL END-DIET ICAM-1 END-DIET
Systemic inflammation selected variables: ICAM-1 (congruence with all indexes),
TNFα (congruence with IT mean, IT median, LA mean). Lipoproteins selected:
ox-LDL (congruence with IT mean, LA median), HDL end-diet (congruence with
IT median, LA median).
side, when considering artery specific factor congruence is lim-
ited to the combination of one IT and one LA index for CATA
(positive association), CATD (positive), BGH3 (positive), S10AA
(positive) and for Fatty acid-binding protein 3 (FABPH, with a
negative association) (Figure 2).
Inclusion of regression coefficients, in variables selected by
the model from separate run on HF and HHF groups, strongly
restricts the relevance of results. No congruence is present, nei-
ther in absolute values nor in the sign of coefficients, what-
ever combination of dependent variables (histologic indexes) is
considered.
DISCUSSION
The aim of this study is to propose a systems biology oriented
approach as a tool to associate circulatory and tissue markers
Table 2 | Artery secreted proteins.
Model selected proteins
IT mean IT median LA mean
IT median CATA, G3P, S10AA,
CPNS1





LA median CATA, BGH3, G3P,
CATD, ANXA4
CATA, G3P, PPCE BGH3, CATA,
CATD, PPCE
Selected proteins: CATA (Catalase) is congruent with all indexes and combi-
nations of histology indexes, CATD (Cathepsin D) with all indexes but not all
combinations, S10AA (S100 A10) and CPNS1 (Calpain small subunit 1) with IT
mean, IT median, LA mean, G3P (Glyceraldehyde-3-phosphate dehydrogenase)
with IT mean, IT median, LA median, BGH3 (Transforming growth factor-beta-
induced protein ig-h3) and ANXA4 (Annexin A4) with IT mean, LA mean, LA
median, PPCE (Prolyl endopeptidase) with IT median, LA mean, LA median.
with coronary lesion development in a high cholesterol diet swine
model. Using animal models, systemic and tissue data can be col-
lected and analyzed at the early stages of diet-accelerated process
and can be useful to define the timing of events that are mostly
uninvestigable in the clinical setting.
Among animal models of atherogenesis, pig is currently con-
sidered the most suitable among those closer to human pathology
(Vilahur et al., 2011).
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FIGURE 2 | (A) Plots of selected circulatory variables (as shown by different
symbols) with their coefficients (Y-axis). (B) Plots of selected, secreted
proteins (as shown by different symbols) with their coefficients (Y-axis).
Histomorphometry data on the X-axis are the dependent variables. Only
independent variables (circulatory factors or secreted proteins) with the
combined highest coefficients and congruent signs (i.e., inverse, negative
sign, or direct, positive sign, correlations), for at least two dependent
variables, are chosen and reported.
Coronary histology indexes, plasma lipoproteins, circulatory
cytokines, adhesion molecules and coronary specific secreted
proteins were provided to the mathematical model and were cho-
sen considering the current knowledge on factors involved in
atherogenesis (Libby et al., 2002; Mohler et al., 2008).
The rationale of exploiting systems approaches through statis-
tical models to elucidate the association between all these factors
originates from the need of pointing out relationships strongly
associated to coronary early atherosclerotic changes. It is known
that the interplay between circulatory and tissue markers and
the association between molecular factors and plaque growth
represent the crossroad of blood-artery wall events during athero-
genesis (Döring et al., 2012). Computational tools like those
described, which run on a multitude of variables simultaneously,
perform variable selection and model optimization, may help
toward the ultimate aim of predictive inference, without bringing
the burden of noisy and spurious correlative associations.
BMA APPROACH TO EXPERIMENTAL DATA
The model application to the provided data sets, followed by a
post-processing exclusion based on the criteria of absolute values
and sign of correlation coefficients, has evidenced that no con-
gruence of any of the independent variables considered for all the
chosen histology indexes is present, neither in the pooled nor in
the separate HF andHHF data implementation runs. This finding
is not surprising and underlies the limitations of this approach
for pathophysiologic investigations when a reduced number of
data is provided to the statistical tool. Despite such limitation,
a restricted number of variables (two lipoproteins, one cytokine
and five proteins) is finally suggested as robustly associated to
both IT and LA morphologic indexes of atherogenesis outcome
when HF and HHF cases are pooled. Separate analysis of the two
groups does not lead to a robust selection of any variable under
the criteria adopted, possibly because of the further reduction of
data available for the model.
BIOLOGICAL RELEVANCE OF MODEL RESULTS
The most robust association between dependent (histology
indexes of atherosclerotic burden) and independent (circula-
tory and local factors) variables has been found when con-
sidering HF and HHF cases as a single group. This finding
may be the consequence of model limitations (low number
of early atherogenesis HF cases) although common mecha-
nisms of initiation and of early plaque growth can also be
hypothesized.
Circulatory associated variables are LDL, oxLDL, and TNFα
and artery-specific variables are CATA, CATD, S100-A10, BGH3,
and FABPH. It must be emphasized that, at variance with con-
ventional statistical tools, the BMAmathematical model accounts
for all the possible associations and blood-tissue factor interre-
lations in selecting those relevant for histologically determined
atherogenesis outcome.
BMA selection of circulatory variables supports the current
view that atherogenesis in a high cholesterol diet experimen-
tal model is related to systemic proinflammatory cytokines and
adhesion molecules under a LDL-rich blood environment. The
impact of inflammation-immunity state on pathology outcome
has been demonstrated by several previous experimental and
clinical studies, both as a strong proatherogenic determinant
of plaque initiation as well as of its progression and evolution
(Lamon and Hajjar, 2008; Merched et al., 2008).
By the mathematical model, identified local artery-specific
factors, relevantly associated to lesion initiation and growth,
are those mainly involved in macrophage/phagocytosis function
and immunity-inflammatory pathways (CATA, CATD, S100-A10,
FABPH, BGH3) (Haidar et al., 2006; Nacu et al., 2008; O’Connell
et al., 2010; Lee et al., 2013). These proteins may be viewed as
mediators and possible markers of a local inflammation scenario
with pro- and anti-inflammatory elements playing a role in both
initiation and early growth of high cholesterol diet-induced coro-
nary atherosclerotic lesions. Among those, negative association is
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evidenced only for FABPH, in contrast with current knowledge
on the role of this protein in atherogenesis (Lee et al., 2013).
CONCLUDING REMARKS
An integrative systems approach is proposed to study the asso-
ciation between circulatory markers and omics data to coronary
atherosclerosis severity. BMA variable selection was chosen as
a method to identify relevant factors associated to atheroscle-
rosis. Specifically, TNFα was identified as an associated plasma
marker, oxLDL and HDL were confirmed as relevant lipopro-
teins, macrophage related antioxidant Catalse enzyme, lysosome
associated Cathepsin D, S100-A10 and Transforming growth
factor-beta-induced protein ig-h3 were selected as associated to
atherogenesis outcome.
The proposed approach has been shown to be feasible from a
computational standpoint and capable of helping in understand-
ing the association of multilevel factors in atherosclerotic plaque
initiation with early growth.
The results of this study suggest a relevant conclusion: in
a high-cholesterol diet-induced model of coronary artery dis-
ease, systemic inflammation impacts on atherogenesis outcome
and it is specifically reflected bymacrophage/phagocytosis-related
artery-specific protein expression. Further studies integrating
genomics, epigenomics and transcriptomics are needed for a bet-
ter assessment of causative mechanisms and sequence of events in
the early phase of atherogenesis in coronary artery disease.
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